| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |